Combined therapy of mesenchymal stem cells with a GLP-1 receptor agonist, liraglutide, on an inflammatory-mediated diabetic non-human primate model
Roghayeh Navabi, Babak Negahdari, Ensiyeh Hajizadeh‐Saffar, Mostafa Hajinasrollah, Yaser Jenab, Shahram Rabbani, Mohamad Pakzad, Seyedeh‐Nafiseh Hassani, Maryam Hezavehei, Mohammad Jafari Atrabi, Yaser Tahamtani, Hossein Baharvand
Topics & Concepts
LiraglutideMedicineStreptozotocinAgonistStem-cell therapyDiabetes mellitusMesenchymal stem cellInternal medicineEndocrinologyIsletReceptorTransplantationType 2 diabetesPathologyPancreatic function and diabetesMesenchymal stem cell researchDiabetes and associated disorders